Company: SMNR
Filing Date: 2025-08-13
Form Type: 424B3
Source: 0001193125-25-179226
Chunk: 112

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: 424B3
Chunk 112
---
 through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions.                                                       |
| Denali Private Placement Units (and the securities underlying the Denali Private Placement 
 Units)                                                                                     |     | 30 days after the completion of a business combination. |     | The Sponsor.       |     | Same as above.                                                                                                                                                                                                                  |
| Shares that may be issued upon conversion of working capital loans                         |     | 30 days after the completion of a business combination. |     | The Sponsor.       |     | Same as above.                                                                                                                                                                                                                  |

Roles and Responsibilities of the directors and officers of Denali, the Sponsor and US Tiger Securities The material roles and responsibilities of the directors of Denali in directing and managing Denali’s activities include managing the business of Denali, authorizing the payment of dividends, appointing officers as they consider necessary, and establishing committees, local boards or agencies or appointing any person to be a manager or agent for managing the affairs of Denali. The material roles and responsibilities of the officers of Denali include identifying potential target businesses and performing due diligence on suitable business combinations. Denali’s sponsor is Denali Capital Global Investments LLC, a Cayman Islands limited liability company formed by Jiandong (Peter) Xu. The Sponsor was responsible for organizing, directing and managing the business and affairs of Denali from its incorporation, through the consummation of the IPO and until Closing. The Sponsor’s activities included identifying and negotiating terms with the Denali Underwriters, other third-party service

56

providers such as Denali’s auditors and legal counsel, fairness opinion providers and Denali’s directors and officers, and searching for and negotiating with potential business combination targets. The Sponsor also provides working capital and advances funds used for transaction expenses to Denali from time to time. Other than its investment in Denali and its work on behalf of Denali, the Sponsor is not engaged in any other business. Denali’s chief executive officer and director, Lei Huang, is also the chief executive officer of US Tiger Securities, a representative to the underwriters to the IPO, and Denali may utilize Mr. Huang’s affiliation with US Tiger Securities during its search for suitable targets. Denali may also engage US Tiger Securities to act as its advisor in connection with the marketing of its business combination and pay US Tiger Securities a fee for such services upon consummation of our initial business combination. Experience of the directors and officers of Denali, the Sponsor and US Tiger Securities